Trial
NCT05330286
Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Healthy Volunteers
Intervention
LMI070
Why stopped
The compound is no longer suitable for further clinical development due to a safety finding in a later phase program.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-14